Lv52
1160 积分 2023-08-15 加入
Preclinical Evaluation of VB6-845: An Anti-EpCAM Immunotoxin with Reduced Immunogenic Potential
28天前
已完结
Production of novel recombinant anti-EpCAM antibody as targeted therapy for breast cancer
28天前
已完结
Development of a GMP Phase III purification process for VB4-845, an immunotoxin expressed in E. coli using high cell density fermentation
28天前
已完结
VB4-845, a conjugated recombinant antibody and immunotoxin for head and neck cancer and bladder cancer
28天前
已关闭
Preclinical Assessment of an Anti-EpCAM Immunotoxin: Locoregional Delivery Provides a Safer Alternative to Systemic Administration
28天前
已完结
Structure and Properties of the Glomerular Filtration Barrier in Vertebrates: Role of a Charge in Protein Filtration
1个月前
已完结
Therapeutic efficacy of heterogeneously distributed radiolabelled peptides: Influence of radionuclide choice
1个月前
已完结
ImmunoPET imaging of EpCAM in solid tumours with nanobody tracers: a preclinical study
1个月前
已完结
Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [99mTc]Tc(CO)3-(HE)3-Ec1 for Visualization of EpCAM-Expressing Lung Cancer
2个月前
已完结
DARPins Recognizing the Tumor-Associated Antigen EpCAM Selected by Phage and Ribosome Display and Engineered for Multivalency
2个月前
已完结
皖公网安备34019202002308
